Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

596 Articles

Douglas A. McIntyre | Dec 10, 2008 at 8:50 AM EST

Top Pre-Market Analyst Upgrades (ALU, ASR, BMY, DD, FORR, HE, QCOM)

There are few positive calls this morning from Wall Street analysts, but these are the ones we have caught this…

Douglas A. McIntyre | Nov 7, 2008 at 8:09 AM EST

Top Pre-Market Analyst Upgrades (ANF, BMY, CECO, EW, WYE)

These are some of the top analyst upgrades we have seen this Friday morning: Abercrombie & Fitch (ANF) Raised to…

Douglas A. McIntyre | Oct 14, 2008 at 5:16 AM EDT

Earnings On Deck: Only Nine Companies Will Matter

Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number…

Douglas A. McIntyre | Oct 6, 2008 at 8:40 AM EDT

Icahn Wins Blue Ribbon in ImClone Race (IMCL, LLY, BMY, MRK)

Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading…

Douglas A. McIntyre | Sep 23, 2008 at 11:07 AM EDT

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…

Douglas A. McIntyre | Sep 23, 2008 at 2:51 AM EDT

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments.…

Douglas A. McIntyre | Sep 15, 2008 at 9:26 AM EDT

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…

Douglas A. McIntyre | Sep 11, 2008 at 10:03 AM EDT

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…

Douglas A. McIntyre | Sep 10, 2008 at 8:21 AM EDT

Day Trader Alert: ImClone Systems (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…

Douglas A. McIntyre | Aug 5, 2008 at 2:40 AM EDT

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company’s annula meeting…

Douglas A. McIntyre | Aug 4, 2008 at 8:21 AM EDT

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…

Douglas A. McIntyre | Aug 1, 2008 at 2:50 AM EDT

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, GM (GM) is expected to post a huge loss. Reuters reports that oil company profits rose, but…

Douglas A. McIntyre | Jul 31, 2008 at 6:59 AM EDT

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…

Douglas A. McIntyre | Jul 16, 2008 at 7:42 AM EDT

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating…

Douglas A. McIntyre | Jun 20, 2008 at 2:21 PM EDT

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

If you thought this was a bad day for the market with the DJIA trading well under that 12,000 psychological…

1 … 36 37 38 39 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Pre-Market Analyst Upgrades (ALU, ASR, BMY, DD, FORR, HE, QCOM)

Top Pre-Market Analyst Upgrades (ANF, BMY, CECO, EW, WYE)

Earnings On Deck: Only Nine Companies Will Matter

Icahn Wins Blue Ribbon in ImClone Race (IMCL, LLY, BMY, MRK)

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Pre-Market Analyst Upgrades (ALU, ASR, BMY, DD, FORR, HE, QCOM)

Top Pre-Market Analyst Upgrades (ANF, BMY, CECO, EW, WYE)

Earnings On Deck: Only Nine Companies Will Matter

Icahn Wins Blue Ribbon in ImClone Race (IMCL, LLY, BMY, MRK)

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Media Digest 9/23/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Media Digest 8/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

52-Week Low Club (WTR, BMY, CELL, DDS, EK, EXPE, GCI, GE, HST, NOK, PFE, Q, VLO, WY, WGO)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income